LFAC Leapfrog management outlines targeted crosssector expansion plans following its latest quarterly earnings release UVE UNIVERSAL delivers 425 percent Q1 2026 EPS beat shares rise 314 percent on upbeat investor reaction Is Vera Therapeutics VERA stock slowing down Vera Therapeutics reports wider loss on 63 EPS miss